Protalix Biotherapeutics Inc (PLX) has fallen Monday morning, with the stock falling -4.39% in pre-market trading to 1.09. PLX's short-term technical score of 95 indicates that the stock has traded more bullishly over the last month than 95% of stocks on the market. In the Biotechnology industry, which ranks 118 out of 146 industries, Protalix Biotherapeutics Inc ranks higher than 96% of stocks. Protalix Biotherapeutics Inc has fallen 5.00% over the past month, closing at $1.13 on August 22. During this period of time, the stock fell as low as $1.03 and as high as $1.20. The company has an average price target of $11.00.
PLX has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on PLX!